Membres de l'équipe

Bouloumié Diehl
Anne
(DR2 INSERM)

Bouloumié Diehl Anne (DR2 INSERM)

anne.bouloumie@inserm.fr

0561325642

Galitzky
Jean
(CRN INSERM)

Galitzky Jean (CRN INSERM)

jean.galitzky@inserm.fr

0561325640

Briot
Anaïs
(CRN INSERM)

Briot Anaïs (CRN INSERM)

anais.briot@inserm.fr

0561325640

Carpéné
Christian
(CRN INSERM)

Carpéné Christian (CRN INSERM)

christian.carpene@inserm.fr

0561325640

Lafontan
Max
(DR0 )

Lafontan Max (DR0 )

max.lafontan@inserm.fr

0561325641

Zakaroff Girard
Alexia
(IE1 UPS)

Zakaroff Girard Alexia (IE1 UPS)

alexia.zakaroff@inserm.fr

0561325640

Bessede
Pauline
(AI INSERM)

Bessede Pauline (AI INSERM)

pauline.bessede@inserm.fr

0561325641

Boulet
Nathalie
(PostDoc)

Boulet Nathalie (PostDoc)

nathalie.boulet@inserm.fr

0561325641

Jargaud
Valentin
(Doc CIFRE)

Jargaud Valentin (Doc CIFRE)

valentin.jargaud@inserm.fr

0561325637

Murphy
Lucie
(AI)

Murphy Lucie (AI)

lucie.murphy@inserm.fr

0561325637

Fontaine
Jessica
(AI)

Fontaine Jessica (AI)

jessica.fontaine@inserm.fr

0561325637

Lasbories
Antoine
(TR)

Lasbories Antoine (TR)

PMIDTitreAuteursAnnéeJournal
30650583Past, Present and Future Anti-Obesity Effects of Flavin-Containing and/or Copper-Containing Amine Oxidase InhibitorsCarpéné C, Boulet N, Chaplin A, Mercader J.2019Medicines (Basel)
30919256Effects of the amino acid derivatives, β-hydroxy-β-methylbutyrate, taurine, and N-methyltyramine, on triacylglycerol breakdown in fat cellsLeroux M, Lemery T, Boulet N, Briot A, Zakaroff A, Bouloumié A, Andrade F, Pérez-Matute P, Arbones-Mainar JM, Carpéné C.2019J Physiol Biochem.
30917543Resveratrol Anti-Obesity Effects: Rapid Inhibition of Adipocyte Glucose UtilizationCarpéné C, Les F, Cásedas G, Peiro C, Fontaine J, Chaplin A, Mercader J, López V.2019Antioxidants (Basel)
31186409Lobular architecture of human adipose tissue defines the niche and fate of progenitor cells.Estève D, Boulet N, Belles C, Zakaroff-Girard A, Decaunes P, Briot A, Veeranagouda Y, Didier M, Remaury A, Guillemot JC, Ledoux S, Dani C, Bouloumié A, Galitzky J.2019Nat Commun
31270215Oral Phenelzine Treatment Mitigates Metabolic Disturbances in Mice Fed a High-Fat DietMercader J, Sabater A, Le Gonidec S, Decaunes P, Chaplin A, Gomez-Zorita S, Milagro F, Carpene C.2019J Pharmacol Exp Ther
30400297Resveratrol, Metabolic Syndrome, and Gut MicrobiotaChaplin A, Carpéné C, Mercader J.2018Nutrients
30257452Metabolic Effects of Oral Phenelzine Treatment on High-Sucrose-Drinking MiceCarpéné C, Gómez-Zorita S, Chaplin A, Mercader J.2018Int J Mol Sci
30501400Regulation of glucose metabolism by bioactive phytochemicals for the management of type 2 diabetes mellitusZhao C, Yang C, Wai STC, Zhang Y, P Portillo M, Paoli P, Wu Y, San Cheang W, Liu B, Carpéné C, Xiao J, Cao H.2018Crit Rev Food Sci Nutr
29545239Senescence Alters PPARγ (Peroxisome Proliferator-Activated Receptor Gamma)-Dependent Fatty Acid Handling in Human Adipose Tissue Microvascular Endothelial Cells and Favors InflammationBriot A, Decaunes P, Volat F, Belles C, Coupaye M, Ledoux S, Bouloumié A.2018Arterioscler Thromb Vasc Biol
29582416Body fat reduction without cardiovascular changes in mice after oral treatment with the MAO inhibitor phenelzineCarpéné C, Mercader J, Le Gonidec S, Schaak S, Mialet-Perez J, Zakaroff-Girard A, Galitzky J.2018Br J Pharmacol
29359026Short-term effects of obestatin on hexose uptake and triacylglycerol breakdown in human subcutaneous adipocytesCarpéné C, Les F, Estève D, Galitzky J.2018World J Diabetes
29348496Natriuretic peptides promote glucose uptake in a cGMP-dependent manner in human adipocytes.Coué M, Barquissau V, Morigny P, Louche K, Lefort C, Mairal A, Carpéné C, Viguerie N, Arner P, Langin D, Rydén M, Moro C.2018Sci Rep
30039351Mechanisms of the antilipolytic response of human adipocytes to tyramine, a trace amine present in foodCarpéné C, Galitzky J, Belles C, Zakaroff-Girard A.2018J Physiol Biochem
30018277The Dietary Antioxidant Piceatannol Inhibits Adipogenesis of Human Adipose Mesenchymal Stem Cells and Limits Glucose Transport and Lipogenic Activities in AdipocytesCarpéné C, Pejenaute H, Del Moral R, Boulet N, Hijona E, Andrade F, Villanueva-Millán MJ, Aguirre L, Arbones-Mainar JM.2018Int J Mol Sci
28470788CD36 Is a Marker of Human Adipocyte Progenitors with Pronounced Adipogenic and Triglyceride Accumulation PotentialGao H, Volat F, Sandhow L, Galitzky J, Nguyen T, Esteve D, Åström G, Mejhert N, Ledoux S, Thalamas C, Arner P, Guillemot JC, Qian H, Rydén M, Bouloumié A.2017Stem Cells
28627722Pterostilbene Inhibits Lipogenic Activity similar to Resveratrol or Caffeine but Differently Modulates Lipolysis in AdipocytesGomez-Zorita S, Belles C, Briot A, Fernández-Quintela A, Portillo MP, Carpéné C2017Phytother Res
28465791Insulin-mimetic compound hexaquis (benzylammonium) decavanadate is antilipolytic in human fat cellsCarpéné C, Garcia-Vicente S, Serrano M, Marti L, Belles C, Royo M, Galitzky J, Zorzano A, Testar X.2017World J Diabetes
29158473NOTCH1 is a mechanosensor in adult arteries.Mack JJ, Mosqueiro TS, Archer BJ, Jones WM, Sunshine H, Faas GC, Briot A, Aragón RL, Su T, Romay MC, McDonald AI, Kuo CH, Lizama CO, Lane TF, Zovein AC, Fang Y, Tarling EJ, de Aguiar Vallim TQ,2017Nat Commun
27766585Anatomical distribution of primary amine oxidase activity in four adipose depots and plasma of severely obese women with or without a dysmetabolic profileCarpéné C, Les F, Hasnaoui M, Biron S, Marceau P, Richard D, Galitzky J, Joanisse DR, Mauriège P. 2016J Physiol Biochem
27454451Notch, lipids, and endothelial cellsBriot A, Bouloumié A. Iruela-Arispe ML.2016Curr Opin Lipidol